JVL Associates’s Eli Lilly LLY Stock Holding History

JVL Associates’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$780K	Buy	674 +19	+3%	+$22.4K	0.22%	36
2026 Q2	$786K	Buy	655 +86	+15%	+$87.9K	0.22%	37
2026 Q1	$523K	Buy	569 +22	+4%	+$22.3K	0.18%	40
2025 Q4	$588K	Buy	547 +25	+5%	+$23.9K	0.19%	42
2025 Q3	$398K	Sell	522 -13	-2%	-$9.7K	0.13%	45
2025 Q2	$417K	Buy	535 +26	+5%	+$20.2K	0.15%	43
2025 Q1	$420K	Sell	509 -10	-2%	-$8.32K	0.17%	41
2024 Q4	$401K	Sell	519 -24	-4%	-$19.9K	0.15%	42
2024 Q3	$481K	Sell	543 -41	-7%	-$36.9K	0.19%	38
2024 Q2	$529K	Buy	584 +6	+1%	+$4.8K	0.21%	34
2024 Q1	$450K	Sell	578 -10	-2%	-$7.12K	0.19%	38
2023 Q4	$343K	Buy	588 +180	+44%	+$105K	0.15%	36
2023 Q3	$219K	Buy	+408	New	+$210K	0.11%	36

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

JVL Associates's LLY Position: Q3 2026 in Review

JVL Associates increased its Eli Lilly (LLY) stake by 2.9% in Q3 2026, buying an estimated $22.4K and bringing the position to 674 shares worth $780K. The position accounts for 0.22% of the portfolio, ranked #36.

JVL Associates first reported a position in LLY in Q3 2023 and has held it in 13 quarters since. The position peaked at $786K in Q2 2026. 2,846 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

JVL Associates held 674 shares of Eli Lilly worth $780K as of Q3 2026.
JVL Associates bought 19 Eli Lilly shares in Q3 2026, an estimated $22.4K.
Eli Lilly made up 0.22% of JVL Associates's portfolio in Q3 2026, its #36 holding.
JVL Associates first reported a position in Eli Lilly in Q3 2023 and has held it in 13 quarters since.
JVL Associates's Eli Lilly position peaked at $786K in Q2 2026.
2,846 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on JVL Associates's 13F filing for Q3 2026, filed 9 Oct 2026.